HLF Herbalife Ltd. Common Shares

NYSE · Consumer products · View on SEC EDGAR ↗
$12.73
Price · Aug 19, 2026
Fundamentals as of Aug 5, 2026

About Herbalife Ltd. Common Shares Company overview from Wikipedia

Herbalife Nutrition Ltd., also called Herbalife International, Inc. or simply Herbalife, is an American multinational multi-level marketing (MLM) corporation that develops and sells dietary supplements.

Read more

Herbalife Nutrition Ltd., also called Herbalife International, Inc. (with a U.S. subsidiary called Herbalife International of America) or simply Herbalife, is an American multinational multi-level marketing (MLM) corporation that develops and sells dietary supplements.

The company was founded by Mark R. Hughes in 1980, and employs an estimated 9,900 people worldwide. The company operates in 95 countries through a network of approximately 4.5 million independent distributors and members. In October 2022, previous CEO Michael O. Johnson was appointed as chairman and interim chief executive officer following the departure of John Agwunobi. The business is incorporated in the Cayman Islands, a tax haven, with its corporate headquarters located in Los Angeles, California.

Herbalife has been accused of fraudulently operating a pyramid scheme, deceiving distributors about the amount of income they could expect to earn and that most of their income would be made from recruiting additional distributors instead of from selling merchandise. The company agreed to "fundamentally restructure" its compensation and other benefits in the United States to include tying distributor rewards to verifiable sales, and pay a $200 million fine as part of a 2016 settlement with the U.S. Federal Trade Commission (FTC) following these accusations.

According to a 2007 research paper, some products sold by Herbalife have caused acute hepatitis.

History

In February 1980, Mark R. Hughes began selling the original Herbalife weight management product from the trunk of his car. Hughes often stated that the genesis of his product and program stemmed from the weight loss concerns of his mother Joanne whose premature death he attributed to an eating disorder and an unhealthy approach to weight loss. His first product was a protein shake designed to help people manage their weight. He structured his company using a direct-selling, multi-level marketing model.

In 1982, Herbalife received complaints from the Food and Drug Administration for claims made about certain products and the inclusion of mandrake, poke root, and food-grade linseed oil in another.

The Department of Justice of Canada filed criminal charges against the company in November 1984 for misleading medical claims in advertisements. As a result of the complaints, the company modified its product claims and reformulated the product.

By 1985, Herbalife was considered the fastest-growing private company in America by Inc. after its sales increased from $386 thousand to $423 million over the previous five years. That same year, the California Attorney General sued the company for making inflated claims about the efficacy of its products. The company suffered as a result of the lawsuit and was forced to lay off nearly 800 employees by May 1985. The company settled the suit for $850,000 without admitting wrongdoing.

In 1986, Herbalife became a publicly traded company on the NASDAQ and rebranded itself as Herbalife International. However, as a result of the negative publicity from the FDA lawsuit, the company posted a $3 million loss that year.

By 1988, the company had expanded its reach to Japan, Spain, New Zealand, Israel, and Mexico, and it increased its worldwide sales to $191 million in 1991.

In 1993, the company underwent a secondary offering of five million shares.

The company launched a line of personal care products in 1995 which included fragrances and facial cleansing products.

The company was sued in civil court by two former distributors in 1997 for withholding earned income.

In 1999, Hughes attempted to take the company private after asserting that Wall Street was undervaluing it. While the board approved the buyout offer, shareholders of the company filed a suit against the company because they believed the share price they were offered was unfair. Hughes eventually abandoned his attempt to buy the company and settled the suit with shareholders. On May 20, 2000, Mark Hughes died at age 44. Following his death, the company was led by Christopher Pair until October 2001.

In March 2026, Herbalife acquired Bioniq, a UK-based personalized supplements company that uses blood biomarker analysis to formulate products, for up to US$150 million.

J.H. Whitney & Company and Golden Gate Capital

In 2002, the company was acquired for US$685 million by J.H. Whitney & Company and Golden Gate Capital. Concurrently, plant sources of ephedrine were removed from Herbalife products in 2002 after several U.S. states banned supplements containing such herbs.

In April 2003, Michael O. Johnson joined Herbalife as CEO following a 17-year career with The Walt Disney Company.

On December 16, 2004, the company had an initial public offering on the NYSE of 14.5 million common shares at $14 per share, netting the owners $1.3 billion.

On May 7, 2014, the company announced that it entered into a deal with Bank of America Merrill Lynch to repurchase $266 million of its stock.

The company announced in November 2016 that Chief Operating Officer Richard Goudis would take over the position of CEO in June 2017 and Johnson would transition to Executive Chairman.

In August 2017, the company announced that it would repurchase up to $600 million of its stock.

On April 25, 2018, Herbalife announced that it had changed its name from Herbalife Ltd. to Herbalife Nutrition Ltd. The company also announced that its shareholders had approved a two-for-one stock split.

In January 2019, Herbalife announced that it was replacing Goudis after learning of comments he had made before taking over as CEO that were "contrary to the company’s expense-related policies and business practices” and inconsistent with the company's standards and culture". Former CEO Johnson subsequently took over the role on an interim basis.

In March 2020, John Agwunobi was appointed Chief Executive Officer. Agwunobi departed from Herbalife in October 2022 and Michael O. Johnson was appointed Chairman and interim Chief Executive Officer.

In May 2025, Stephan Gratziani was appointed Chief Executive Officer, becoming the first distributor since founder Mark Hughes to lead the company. Michael O. Johnson transitioned in the position of Executive Chairman.

Products

Herbalife Nutrition's products include weight-loss and protein shakes, as well as protein bars, teas, aloes, vitamins, and sports hydration, energy, and personal care products. The company's original product is the Formula 1 protein shake, a soy-based meal-replacement shake. The product debuted in 1980 and, as of 2015, was the company's best selling product accounting for nearly 30% of total sales.

Herbalife's products are produced at the company's five manufacturing facilities in the U.S. and China, as well as by third-party manufacturing partners. The company's production process is based on a "seed to feed" strategy, which the company initiated in the 2010s that allows it to trace where the ingredients in its nutritional products originated. Since 2013, the company has operated a botanical extraction facility in Changsha, Hunan Province, China. The facility produces botanical extracts, including teas, guarana, chamomile, broccoli, and bilberry, for use in many of the company's products. Before extracts are processed, they undergo a botanical identification program and are tested several times throughout the production process. The processed raw materials from the extraction facility are used at all of the company's branded manufacturing facilities as well as by its partners. As of 2015, 58% of the company's nutrition products were manufactured at Herbalife-owned facilities.

In China, the company's manufacturing sites are located in Suzhou and Nanjing. In the U.S., the company has manufacturing facilities in Lake Forest, California, and Winston-Salem, North Carolina.

Herbalife's claims of health benefits from its products have met scrutiny from the medical community, consumers, and government agencies.

In 2008, Herbalife was sued after laboratory tests indicated that levels of lead in several Herbalife products were in excess of California state law and could lead to liver problems over an extended period of time. The company commissioned its own lab testing and found that those products did not contain high enough amounts of lead to require special labeling.

Business model

Herbalife Nutrition is a multi-level marketing company. A 2010 article in the Los Angeles Business Journal claimed that Herbalife Nutrition was one of the most profitable companies in Los Angeles County and directly benefited from its business model.

As a result of the 2016 FTC settlement, the company is required to prove that at least 80 percent of its sales are made to individuals outside of its distributor network. Distributors are responsible for providing receipts for sales and proving they have legitimate customers. The settlement also required that distributors are only able to earn one-third of their rewards based on recruitment. In the U.S., the company now differentiates between individuals who join as a member to buy discounted products and those who join as a distributor seeking a business opportunity. Discount buyers are unable to earn rewards or sell products. Herbalife Nutrition is also required to have its practices monitored by an outside party for seven years to ensure compliance.

In the past, company management considered the number and retention of distributors a key parameter and tracked it closely in financial reports. By January of each year, sales leaders are required to requalify. In February of each year, individuals who did not satisfy the sales leader qualification requirements during the preceding 12 months are removed from that rank. For the latest 12-month requalification period ending January 2019, approximately 67.9 percent of the eligible sales leaders requalified.

In a California class action suit (Minton v. Herbalife International, et al.) filed on February 17, 2005, the plaintiff challenged "the marketing practices of certain Herbalife International independent distributors under various state laws". In a West Virginia class action suit (Mey v. Herbalife International, Inc., et al.) filed on July 16, 2003, the plaintiffs alleged that some of Herbalife International's distributors used pre-recorded telephone messages and autodialers to contact prospective customers in violation of the Telephone Consumer Protection Act. The case was resolved with Herbalife and its distributors paying $7 million into a fund for class members part of the suit.

Liver disease inquiries

Hospitals in Israel, Spain, Switzerland, Iceland, Argentina, and the United States have reported liver damage in a number of patients who used Herbalife products.

In 2004, Israel's Health Minister began an investigation into Herbalife's products after four persons using Herbalife's products were found to have liver problems. The company was criticized for the presence of lead and other heavy metals in some of its products, with comfrey specifically flagged for its association with liver toxicity. The products were sent to Bio-Medical Research Design LTD (B.R.D), to a private U.S. laboratory, and to Israel's Forensic research laboratory. A study of the cases funded by the Israeli Ministry of Health concluded that there was a causative relationship. Herbalife's SEC 10-Q filings stated that the Israeli Ministry of Health did not establish a causal relationship between the product and liver ailments. In 2009, an Israeli woman sued Herbalife International and Herbalife Israel, claiming that her liver damage resulted from the use of Herbalife products.

Scientific studies in 2007 by doctors at the University Hospital of Bern in Switzerland and the Liver Unit of the Hadassah-Hebrew University Medical Center in Israel found an association between consumption of Herbalife products and hepatitis. In response, the Spanish Ministry of Health issued an alert asking for caution in consuming Herbalife products. Herbalife stated they were cooperating fully with Spanish authorities, and after investigation, the agency determined no action was required and removed the alert.

In January 2009, the Scientific Committee of the Spanish Agency for Food Safety and Nutrition (AESAN) reached the same conclusion. After reviewing cases implicating Herbalife products in Spain, Switzerland, Israel, Finland, France, Italy, Iceland and Portugal, the 12-member scientific panel issued a report concluding: "The analyses of these cases and information regarding their circumstances have not allowed us to establish a causal relationship" between liver anomalies and Herbalife's dietary supplements. The panel attributed the cases to metabolic changes from overzealous and unsupervised dieting.

A July 2013 peer-reviewed study published in the World Journal of Hepatology reexamined known cases of hepatotoxicity that had previously been linked to consumption of Herbalife products and concluded that using "the liver specific Council for International Organizations of Medical Sciences scale, causality was probable in 1 case, unlikely and excluded in the other cases. Thus, causality levels were much lower than hitherto proposed". In a separate review published less than a year earlier, the same author described the relationship between Herbalife products and reported hepatotoxicity cases as "highly probable".

In 2019, the Journal of Clinical and Experimental Hepatology published a paper titled "Slimming to the Death: Herbalife-Associated Fatal Acute Liver Failure-Heavy Metals, Toxic Compounds, Bacterial Contaminants and Psychotropic Agents in Products Sold in India". This paper examined the connection between Herbalife slimming products and a case of fatal acute liver failure in one patient in India. In December 2020, the journal retracted the aforementioned article, contrary to the COPE guidelines, which advise that the original paper should remain available but prominently marked as retracted. According to one of the co-authors of the paper, this retraction happened because Herbalife engaged DSK Legal, a New Delhi–based law firm, to consistently issue legal threats to the journal's editor-in-chief.

Pyramid scheme allegations

Critics of the company's structure have contended that it has operated as a pyramid scheme. They have also argued that the company does not sufficiently work to curb abuses by individual distributors, though Herbalife Nutrition has consistently denied the allegations.

A 2004 settlement resolved a class-action suit on behalf of 8,700 former and current distributors who accused the company and distributors of "essentially running a pyramid scheme". A total of $6 million was to be paid out, with defendants not admitting guilt.

In November 2011, the Commercial Court in Brussels, Belgium, ruled that Herbalife was an illegal pyramid scheme. The company filed an appeal on March 8, 2012. On December 3, 2013, a Belgian appeals court found for Herbalife, reversing the lower court's finding.

On May 1, 2012, a short seller, David Einhorn, asked questions about the company's business and sales models during the Q1 earnings call, setting off suspicions that Einhorn had a short position. These suspicions were proved correct in January 2013 when at an investor meeting Einhorn revealed that he had profited through a short position against the company. Einhorn said the short had been closed before the end of 2012.

Bill Ackman

On December 20, 2012, Bill Ackman (of Pershing Square Capital) presented a series of arguments outlining why his firm believed that Herbalife operated a "sophisticated pyramid scheme" and contended that its stock would hit zero. Ackman alleged after a year-long investigation that the majority of distributors lose money, that the chance of making the testimonial-implied headline income is approximately one in five thousand, and that the company materially overstates its distributors' retail sales and understates their recruiting rewards.

According to a number of financial commentators, Ackman bet roughly $1 billion against the company; soon after remarks to the press, the price of the stock decreased such that Ackman would have made $300 million if he had closed his short position then. In March 2015, federal prosecutors and the FBI revealed that they were investigating whether or not individuals paid by Ackman and otherwise had made false statements about Herbalife's business model to regulators and others in order to lower the company's stock price and influence authorities to conduct an investigation.

In November 2017, Ackman closed out his short position after Herbalife shares increased by 51 percent over the year, and replaced it with a less aggressive put option. In March 2018, The Wall Street Journal reported that Ackman had "largely exited" his bet against the company, while others reported that the bet against Herbalife had cost his company hundreds of millions of dollars and damaged the confidence of investors in his hedge fund.

FTC investigation

Based on information from a Freedom of Information Act (FOIA) request, the New York Post reported on February 4, 2013, that Herbalife was subject to a pending probe from the Federal Trade Commission (FTC). The FTC released 729 pages containing 192 complaints received over a seven-year period in regards to the New York Post's FOIA request. The FTC stated that the wording in its response to the FOIA request was incorrect; the FTC could not confirm or deny an investigation into Herbalife.

In March 2014, the FTC opened an investigation into Herbalife in response to calls from consumer groups and members in both houses of the United States Congress. Herbalife responded to the probe by saying it "welcomes the inquiry given the tremendous amount of misinformation in the marketplace, and will cooperate fully with the FTC. We are confident that Herbalife is in compliance with all applicable laws and regulations". However, in the press conference, Herbalife was declared not necessarily not a pyramid scheme.

In July 2016, Herbalife agreed to modify its business model and pay $200 million in a settlement with the FTC. Partial refund checks were mailed to roughly 350,000 Herbalife distributors in January 2017. The FTC said in a press release about the settlement "it's virtually impossible to make money selling Herbalife products."

The lawsuit alleged Herbalife deceived consumers into believing they could earn substantial income from the business opportunity or big money from the retail sale of the company's products. In addition, the complaint charged that one of the fundamental principles of Herbalife's business model—incentivizing distributors to buy products and to recruit others to join and buy products so they could advance in the company's marketing program, rather than in response to actual consumer demand—is an unfair practice in violation of the FTC Act.

The company remained under investigation as of early 2019 both by the United States Department of Justice (DOJ) and the U.S. Securities and Exchange Commission (SEC) for corruption in China.

On September 27, 2019, the SEC announced Herbalife agreed to pay $20 million to settle charges of making false and misleading statements about its business model and operations in China between 2012 and 2018. The company did not admit or deny the charges but agreed to the settlement terms.

U.S. Department of Justice investigation of bribery in China

In 2019, the DOJ charged two of Herbalife's employees with conspiracy in violation of the Foreign Corrupt Practices Act (FCPA). They were accused of bribing Chinese officials to procure sales permits and influence an investigation into Herbalife. They were also accused of offering bribes to China Economic Net to influence media coverage. In response, Herbalife committed $40 million to resolve the issues, and began negotiations with both the DOJ and SEC. In August 2020, Herbalife agreed to pay $123 million to the DOJ and the U.S. Securities and Exchange Commission.

Sports sponsorships

Herbalife has sponsored France's national volleyball team and the Major League Soccer club LA Galaxy since 2007 and has sponsored Cristiano Ronaldo since 2013. They sponsored FC Barcelona and Lionel Messi between 2010 and 2013. Herbalife has also sponsored the basketball club Herbalife Gran Canaria since 2012. In July 2020, Herbalife also sponsored the Guangzhou Charge of the Overwatch League. In addition to these team and player sponsorships, Turkish Women's Basketball Super League has been named 'Herbalife Nutrition Women's Basketball Super League' for three years starting the 2019-2020 regular season.

During the 2020 Summer Olympics, Herbalife Nutrition was a sponsor of the Olympic Committee of Israel and the Indian Olympic Association. In 2023, Herbalife became a sponsor of the Indian Premier League.

In 2023, the company became the main shirt sponsor of the Western Sydney Wanderers FC women's football team.

Herbalife has also sponsored Indian cricket star and former captain Virat Kohli since 2011-2025. They have also sponsored other Indian athletes including Smriti Mandhana, Manika Batra, Lakshya Sen, and Palak Kohli.

Media

In April 2016, a documentary directed by Ted Braun, titled Betting on Zero, premiered at the Tribeca Film Festival. It explored the allegation from Bill Ackman that Herbalife was a pyramid scheme and personal stories of its distributors who lost their life savings. Hilary Rosen, a Democratic lobbyist and an adviser to Herbalife, questioned Tribeca's credibility after claiming that the film was "bought and paid" for by Ackman "to make good on his stock bet".

In 2016, a Last Week Tonight with John Oliver segment on multi-level marketing focused on Herbalife; it strongly condemned the company for its structure resembling a pyramid scheme and cited the FTC report, which implied the company had been operating illegitimately. Oliver criticized Herbalife for its exploitation of Latino communities, and overstatement of its products' health benefits. One reviewer wrote that it appeared to be largely based on Betting on Zero, and caused no immediate change in Herbalife's stock prices.

The 2018 book When The Wolves Bite: Two Billionaires, One Company, and an Epic Wall Street Battle by Scott Wapner discusses Ackman's short of the company and his battle with Carl Icahn. In the book, Wapner characterizes Ackman's decision to bet against Herbalife as dangerous, because it anticipated that the government would shut Herbalife down.

Source: Wikipedia, CC BY-SA 4.0 · View on Wikipedia ↗

Wikidata ↗

HLF Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$12.73
Market Cap
$1.32B
P/E (TTM)
5.8
EPS (TTM)
$2.20
Revenue (TTM)
$5.04B
Div Yield
0.00%
ROE
-34.7%
Debt/Equity
-3.9
52W Range
$8 – $20

HLF Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income $5.04B
10-point trend, +12.2%
2016-12-31 2025-12-31
EPS $2.20
10-point trend, +45.7%
2016-12-31 2025-12-31
Free Cash Flow $253M
10-point trend, +13.0%
2016-12-31 2025-12-31
Margins 4.5%
10-point trend, -3.8%
2016-12-31 2025-12-31

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
HLF
Peer Median
P/E (TTM)
5-point trend, -40.9%
5.8
11.4
P/S (TTM)
5-point trend, -62.8%
0.3
0.7
P/B
5-point trend, +12.8%
-2.6
1.5
EV / EBITDA
5-point trend, -27.9%
6.1
Price / FCF
5-point trend, -60.6%
5.2

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
HLF
Peer Median
Gross Margin
5-point trend, -1.0%
77.9%
33.1%
Operating Margin
5-point trend, -24.5%
9.6%
Net Profit Margin
5-point trend, -41.2%
4.5%
5.5%
ROA
5-point trend, -45.4%
8.3%
4.7%
ROE
5-point trend, -5.7%
-34.7%
12.8%
ROIC
5-point trend, -36.9%
27.0%

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
HLF
Peer Median
Debt / Equity
5-point trend, -94.9%
-3.9
57.5
Current Ratio
5-point trend, -14.7%
1.1
3.0
Quick Ratio
5-point trend, -29.0%
0.4

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
HLF
Peer Median
Revenue YoY
5-point trend, -13.2%
0.89%
Revenue CAGR 3Y
5-point trend, -13.2%
-1.1%
Revenue CAGR 5Y
5-point trend, -13.2%
-1.9%
EPS YoY
5-point trend, -46.7%
-12.0%
Net Income YoY
5-point trend, -48.9%
-10.2%

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
HLF
Peer Median
EPS (Diluted)
5-point trend, -46.7%
$2.20

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
HLF
Peer Median

Dividends Yield, payout ratio, dividend history, 5Y CAGR

Dividend Yield
0.00%
Payout Ratio
5Y Div CAGR
Ex-dateAmount
Feb. 28, 2014$0.1500
Nov. 7, 2013$0.1500
Aug. 9, 2013$0.1500
May 10, 2013$0.1500
March 1, 2013$0.1500
Nov. 9, 2012$0.1500
Aug. 10, 2012$0.1500
May 11, 2012$0.1500
March 5, 2012$0.1500
Nov. 9, 2011$0.1000
Aug. 11, 2011$0.1000
May 20, 2011$0.0500
March 4, 2011$0.0625
Nov. 10, 2010$0.0625
Aug. 10, 2010$0.0625
May 6, 2010$0.0500
Feb. 26, 2010$0.0500
Nov. 23, 2009$0.0500
Aug. 26, 2009$0.0500
May 20, 2009$0.0500

HLF Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 8 analysts
  • Strong Buy 3 37.5%
  • Buy 3 37.5%
  • Hold 1 12.5%
  • Sell 1 12.5%
  • Strong Sell 0 0.0%

12-Month Price Target

3 analysts · 2026-08-15
Median target $17.00 +33.5%
Mean target $17.00 +33.5%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise
0.08%
Period EPS Actual EPS Est Surprise
June 30, 2026 $0.51 $0.54 -0.03%
March 31, 2026 $0.64 $0.58 0.06%
Dec. 31, 2025 $0.45 $0.43 0.02%
Sept. 30, 2025 $0.50 $0.47 0.03%
June 30, 2025 $0.59 $0.39 0.20%
March 31, 2025 $0.59 $0.37 0.22%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Income Statement 16
Annual Income Statement data for HLF
Metric Trend 202520242023202220212020201920182017201620152014
Revenue 12-point trend, +1.6% $5.04B $4.99B $5.06B $5.20B $5.80B $5.54B $4.88B $4.89B $4.43B $4.49B $4.47B $4.96B
Cost of Revenue 12-point trend, +13.4% $1.11B $1.10B $1.19B $1.17B $1.24B $1.15B $958M $919M $849M $855M $856M $983M
Gross Profit 12-point trend, -1.3% $3.92B $3.89B $3.87B $4.03B $4.56B $4.39B $3.92B $3.97B $3.58B $3.63B $3.61B $3.98B
SG&A Expense 12-point trend, -16.4% $1.66B $1.73B $1.70B $1.81B $2.01B $2.08B $1.94B $1.96B $1.76B $1.97B $1.78B $1.99B
Operating Income 12-point trend, -6.3% $481M $386M $356M $545M $734M $641M $568M $683M $617M $458M $584M $514M
Interest Expense 12-point trend, +133.8% $214M $218M $166M $139M $153M $133M $153M $181M $161M $99M $100M $92M
Interest Income 4-point trend, +16.0% · · · · · · · · $14M $6M $6M $12M
Other Non-op 11-point trend, +100.0% $0 $-10M $1M $13M $-25M $0 $-16M $-57M $400.0K · $-2M $-13M
Pretax Income 12-point trend, -34.7% $275M $169M $203M $425M $561M $516M $451M $464M $471M $365M $486M $421M
Income Tax 12-point trend, -58.0% $47M $-85M $61M $104M $114M $144M $140M $168M $257M $105M $147M $113M
Net Income 12-point trend, -26.0% $228M $254M $142M $321M $447M $373M $311M $297M $214M $260M $339M $309M
EPS (Basic) 12-point trend, -38.0% $2.22 $2.53 $1.44 $3.26 $4.22 $2.83 $2.26 $2.12 $1.35 $1.57 $4.11 $3.58
EPS (Diluted) 12-point trend, -35.3% $2.20 $2.50 $1.42 $3.23 $4.13 $2.77 $2.20 $1.98 $1.29 $1.51 $3.97 $3.40
Shares (Basic) 12-point trend, +19.1% 102,800,000 100,600,000 99,000,000 98,500,000 105,900,000 131,500,000 137,400,000 140,200,000 158,500,000 166,100,000 82,600,000 86,300,000
Shares (Diluted) 12-point trend, +14.1% 103,600,000 101,600,000 100,200,000 99,500,000 108,300,000 134,500,000 141,600,000 149,500,000 165,700,000 172,200,000 85,300,000 90,800,000
EBITDA 12-point trend, -6.3% $481M $386M $356M $545M $734M $641M $568M $683M $617M $458M $584M $514M
Balance Sheet 28
Annual Balance Sheet data for HLF
Metric Trend 202520242023202220212020201920182017201620152014
Cash & Equivalents 12-point trend, -45.3% $353M $415M $575M $508M $602M $1.05B $839M $1.20B $1.28B $844M $890M $645M
Receivables 12-point trend, +9.9% $92M $69M $81M $71M $67M $83M $80M $70M $93M $70M $70M $84M
Inventory 12-point trend, +35.5% $512M $475M $505M $581M $576M $501M $436M $382M $341M $371M $332M $378M
Prepaid Expense 12-point trend, +1.0% $188M $184M $238M $197M $188M $146M $133M $154M $147M $177M $161M $186M
Current Assets 12-point trend, -17.8% $1.14B $1.14B $1.40B $1.36B $1.43B $1.78B $1.49B $1.80B $1.86B $1.46B $1.57B $1.39B
PP&E (Net) 12-point trend, +22.1% $448M $460M $506M $486M $442M $390M $372M $360M $378M $378M $339M $367M
PP&E (Gross) 12-point trend, +77.7% $1.51B $1.48B $1.52B $1.52B $1.46B $1.32B $1.22B $1.13B $1.08B $982M $877M $850M
Accum. Depreciation 12-point trend, +120.0% $1.06B $1.02B $1.01B $1.03B $1.02B $934M $845M $765M $703M $604M $537M $483M
Goodwill 12-point trend, -1.7% $100M $88M $95M $93M $95M $100M $92M $93M $97M $90M $92M $102M
Intangibles 12-point trend, +1.5% $315M $312M $314M $316M $317M $313M $310M $310M $310M $310M $310M $310M
Other Non-current Assets 12-point trend, -6.2% $145M $140M $129M $274M $313M $274M $228M $222M $250M $325M $141M $155M
Total Assets 12-point trend, +18.3% $2.79B $2.73B $2.81B $2.73B $2.82B $3.08B $2.68B $2.79B $2.90B $2.57B $2.48B $2.35B
Accounts Payable 12-point trend, +37.8% $100M $70M $84M $90M $92M $89M $82M $81M $68M $66M $71M $72M
Accrued Liabilities 3-point trend, -6.0% · · · · · · · · · $237M $229M $252M
Current Liabilities 12-point trend, +15.8% $1.01B $1.23B $1.28B $977M $1.08B $1.13B $964M $1.59B $907M $792M $1.02B $875M
Capital Leases 7-point trend, -8.4% $156M $170M $168M $192M $201M $207M $170M · · · · ·
Deferred Tax 7-point trend, +156.9% · · · · · $39M $21M $8M $8M $15M $400.0K $15M
Other Non-current Liabilities 12-point trend, +139.9% $155M $153M $172M $166M $196M $193M $155M $150M $157M $139M $70M $65M
Total Liabilities 12-point trend, +22.5% $3.30B $3.53B $3.87B $4.00B $4.21B $3.93B $3.07B $3.51B $3.23B $2.37B $2.53B $2.69B
Long-term Debt 12-point trend, +11.2% $1.99B $2.26B $2.56B $2.69B $2.76B $2.43B $1.80B $2.45B $2.27B $1.45B $1.62B $1.79B
Total Debt 12-point trend, +10.0% $1.99B $2.26B $2.56B $2.69B $2.76B $2.43B $1.80B $2.45B $2.27B $1.45B $1.62B $1.81B
Common Stock Flat — no change across 12 periods $100.0K $100.0K $100.0K $100.0K $100.0K $100.0K $100.0K $100.0K $100.0K $100.0K $100.0K $100.0K
Retained Earnings 12-point trend, +12.9% $-580M $-808M $-1.06B $-1.20B $-1.17B $-687M $-215M $-526M $-248M $-66M $-326M $-665M
Treasury Stock 6-point trend, -100.0% · · · $0 $329M $329M $329M $329M $329M · · ·
AOCI 12-point trend, -221.6% $-252M $-271M $-232M $-250M $-212M $-182M $-212M $-210M $-165M $-205M $-166M $-78M
Stockholders' Equity 12-point trend, -54.0% $-515M $-801M $-1.06B $-1.27B $-1.39B $-856M $-390M $-723M $-335M $196M $-54M $-334M
Liabilities + Equity 12-point trend, +18.3% $2.79B $2.73B $2.81B $2.73B $2.82B $3.08B $2.68B $2.79B $2.90B $2.57B $2.48B $2.35B
Shares Outstanding 12-point trend, +12.0% 103,300,000 101,200,000 99,200,000 97,900,000 100,800,000 120,100,000 137,400,000 142,800,000 164,700,000 186,300,000 92,700,000 92,200,000
Cash Flow 16
Annual Cash Flow data for HLF
Metric Trend 202520242023202220212020201920182017201620152014
D&A 12-point trend, +30.0% $121M $121M $113M $115M $108M $100M $98M $100M $100M $98M $98M $93M
Stock-based Comp 12-point trend, -3.5% $44M $50M $48M $44M $54M $51M $39M $36M $42M $40M $45M $46M
Deferred Tax 12-point trend, +24.3% $-64M $-230M $-41M $-30M $-33M $2M $15M $-8M $98M $-36M $-38M $-85M
Amort. of Intangibles · · · · · · · · · · · $300.0K
Restructuring 2-point trend, -89.9% $7M $69M · · · · · · · · · ·
Operating Cash Flow 12-point trend, -34.8% $333M $285M $358M $352M $460M $629M $458M $648M $591M $367M $629M $511M
CapEx 12-point trend, -53.7% $80M $122M $135M $156M $151M $112M $106M $84M $96M $143M $79M $174M
Investing Cash Flow 10-point trend, +23.7% $-109M $-85M $-135M $-156M $-156M $-123M $-108M $-84M $-95M $-142M · ·
Stock Repurchased 12-point trend, -99.4% $8M $8M $11M $147M $1.01B $924M $17M $750M $844M $13M $17M $1.29B
Net Stock Activity 12-point trend, +99.4% $-8M $-8M $-11M $-147M $-1.01B $-924M $-17M $-750M $-844M $-13M $-17M $-1.29B
Dividends Paid 5-point trend, -100.0% · · · · · · · $0 $0 $0 $0 $30M
Financing Cash Flow 10-point trend, -17.1% $-296M $-335M $-148M $-265M $-729M $-321M $-713M $-593M $-85M $-252M · ·
Net Change in Cash 12-point trend, +80.8% $-63M $-157M $79M $-94M $-444M $206M $-368M $-80M $439M $-48M $244M $-328M
Taxes Paid 3-point trend, -3.6% $117M $132M $121M · · · · · · · · ·
Free Cash Flow 12-point trend, -25.1% $253M $163M $222M $196M $309M $517M $351M $564M $495M $224M $550M $338M
Levered FCF 11-point trend, -84.3% $75M $-164M $106M $91M $187M $421M $246M $449M $422M $153M $480M ·
Profitability 8
Annual Profitability data for HLF
Metric Trend 202520242023202220212020201920182017201620152014
Gross Margin 12-point trend, -2.9% 77.9% 77.9% 76.5% 77.5% 78.6% 79.2% 80.4% 81.2% 80.8% 81.0% 80.8% 80.2%
Operating Margin 12-point trend, -7.8% 9.6% 7.7% 7.0% 10.5% 12.7% 11.6% 11.7% 14.0% 13.9% 10.2% 13.1% 10.4%
Net Margin 12-point trend, -27.3% 4.5% 5.1% 2.8% 6.2% 7.7% 6.7% 6.4% 6.1% 4.8% 5.8% 7.6% 6.2%
Pretax Margin 12-point trend, -35.8% 5.5% 3.4% 4.0% 8.2% 9.7% 9.3% 9.3% 9.5% 10.6% 8.1% 10.9% 8.5%
EBITDA Margin 12-point trend, -7.8% 9.6% 7.7% 7.0% 10.5% 12.7% 11.6% 11.7% 14.0% 13.9% 10.2% 13.1% 10.4%
ROA 12-point trend, -35.0% 8.3% 9.2% 5.1% 11.6% 15.2% 13.0% 11.4% 10.4% 7.8% 10.3% 14.0% 12.7%
ROE 12-point trend, -112.2% -34.7% -27.7% -13.1% -24.4% -32.8% -42.1% -72.5% -40.0% -309.1% 364.2% -174.8% 284.5%
ROIC 12-point trend, +5.9% 27.0% 39.7% 16.6% 28.9% 42.7% 29.4% 27.7% 25.2% 14.5% 19.9% 25.9% 25.5%
Liquidity & Solvency 5
Annual Liquidity & Solvency data for HLF
Metric Trend 202520242023202220212020201920182017201620152014
Current Ratio 12-point trend, -29.0% 1.1 0.9 1.1 1.4 1.3 1.6 1.5 1.1 2.1 1.8 1.5 1.6
Quick Ratio 12-point trend, -47.3% 0.4 0.4 0.5 0.6 0.6 1.0 1.0 0.8 1.5 1.2 0.9 0.8
Debt / Equity 12-point trend, +28.6% -3.9 -2.8 -2.4 -2.1 -2.0 -2.8 -4.6 -3.4 -6.8 7.4 -30.3 -5.4
LT Debt / Equity 12-point trend, +25.2% -3.8 -2.5 -2.1 -2.1 -2.0 -2.8 -4.6 -2.5 -6.5 7.3 -26.0 -5.1
Interest Coverage 11-point trend, -61.4% 2.2 1.8 2.1 3.9 4.8 4.8 3.7 3.8 3.8 4.6 5.8 ·
Efficiency 3
Annual Efficiency data for HLF
Metric Trend 202520242023202220212020201920182017201620152014
Asset Turnover 12-point trend, -10.7% 1.8 1.8 1.8 1.9 2.0 1.9 1.8 1.7 1.6 1.8 1.8 2.0
Inventory Turnover 12-point trend, -16.3% 2.3 2.3 2.2 2.0 2.3 2.5 2.3 2.5 2.4 2.4 2.4 2.7
Receivables Turnover 12-point trend, +16.2% 62.7 66.5 66.7 75.7 77.3 68.0 64.9 59.7 54.1 64.0 58.2 53.9
Per Share 6
Annual Per Share data for HLF
Metric Trend 202520242023202220212020201920182017201620152014
Book Value / Share 12-point trend, -37.5% $-4.99 $-7.92 $-10.69 $-12.93 $-13.80 $-7.13 $-2.84 $-5.07 $-4.07 $2.11 $-0.58 $-3.63
Revenue / Share 12-point trend, -11.0% $48.62 $49.14 $50.52 $52.31 $53.58 $41.20 $34.44 $32.72 $53.41 $52.13 $52.39 $54.61
Cash Flow / Share 12-point trend, -42.9% $3.22 $2.81 $3.57 $3.54 $4.25 $4.67 $3.23 $4.34 $7.13 $4.27 $7.37 $5.63
Cash / Share 12-point trend, -51.2% $3.42 $4.10 $5.80 $5.19 $5.97 $8.70 $6.11 $8.40 $15.54 $9.07 $9.60 $7.00
Dividend / Share · · · · · · · · · · · $0
EPS (TTM) 12-point trend, -35.3% $2.20 $2.50 $1.42 $3.23 $4.13 $2.77 $2.20 $1.98 $1.29 $1.51 $3.97 $3.40
Growth Rates 9
Annual Growth Rates data for HLF
Metric Trend 202520242023202220212020201920182017201620152014
Revenue YoY 5-point trend, -81.1% 0.89% -1.4% -2.7% -10.3% 4.7% · · · · · · ·
Revenue CAGR 3Y 3-point trend, +63.6% -1.1% -4.9% -3.0% · · · · · · · · ·
Revenue CAGR 5Y -1.9% · · · · · · · · · · ·
EPS YoY 5-point trend, -124.4% -12.0% 76.1% -56.0% -21.8% 49.1% · · · · · · ·
EPS CAGR 3Y 3-point trend, +39.8% -12.0% -15.4% -20.0% · · · · · · · · ·
EPS CAGR 5Y -4.5% · · · · · · · · · · ·
Net Income YoY 5-point trend, -151.0% -10.2% 78.8% -55.7% -28.1% 20.0% · · · · · · ·
Net Income CAGR 3Y 3-point trend, +60.8% -10.8% -17.2% -27.5% · · · · · · · · ·
Net Income CAGR 5Y -9.3% · · · · · · · · · · ·
Valuation (TTM) 16
Annual Valuation (TTM) data for HLF
Metric Trend 202520242023202220212020201920182017201620152014
Revenue TTM 12-point trend, +1.6% $5.04B $4.99B $5.06B $5.20B $5.80B $5.54B $4.88B $4.89B $4.43B $4.49B $4.47B $4.96B
Net Income TTM 12-point trend, -26.0% $228M $254M $142M $321M $447M $373M $311M $297M $214M $260M $339M $309M
Market Cap 12-point trend, -23.4% $1.33B $677M $1.51B $1.46B $4.13B $5.77B $6.55B $8.42B $2.79B $2.24B $2.49B $1.74B
Enterprise Value 12-point trend, +2.3% $2.97B $2.52B $3.50B $3.64B $6.29B $7.15B $7.51B $9.67B $3.78B $2.84B $3.22B $2.90B
P/E 12-point trend, +5.7% 5.9 2.7 10.7 4.6 9.9 17.3 21.7 29.8 26.2 15.9 6.8 5.5
P/S 12-point trend, -24.6% 0.3 0.1 0.3 0.3 0.7 1.0 1.3 1.7 0.6 0.5 0.6 0.4
P/B 12-point trend, +50.3% -2.6 -0.8 -1.4 -1.2 -3.0 -6.7 -16.8 -11.6 -8.3 11.4 -46.5 -5.2
P / Cash Flow 12-point trend, +17.6% 4.0 2.4 4.2 4.1 9.0 9.2 14.3 13.0 4.7 6.1 4.0 3.4
P / FCF 12-point trend, +2.3% 5.3 4.1 6.8 7.4 13.4 11.2 18.6 14.9 5.6 10.0 4.5 5.1
EV / EBITDA 12-point trend, +9.2% 6.2 6.5 9.8 6.7 8.6 11.2 13.2 14.2 6.1 6.2 5.5 5.7
EV / FCF 12-point trend, +36.6% 11.7 15.4 15.7 18.6 20.4 13.8 21.4 17.1 7.6 12.7 5.9 8.6
EV / Revenue 12-point trend, +0.7% 0.6 0.5 0.7 0.7 1.1 1.3 1.5 2.0 0.9 0.6 0.7 0.6
Dividend Yield 12-point trend, -100.0% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.8%
Earnings Yield 12-point trend, -5.4% 17.1% 37.4% 9.3% 21.7% 10.1% 5.8% 4.6% 3.4% 3.8% 6.3% 14.8% 18.0%
Payout Ratio 5-point trend, -100.0% · · · · · · · 0.00% 0.00% 0.00% 0.00% 9.8%
Annual Payout 12-point trend, -100.0% $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $30M

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

Income Statement
2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue $5.04B$4.99B$5.06B$5.20B$5.80B
Gross Margin % 77.9%77.9%76.5%77.5%78.6%
Operating Margin % 9.6%7.7%7.0%10.5%12.7%
Net Income $228M$254M$142M$321M$447M
Diluted EPS $2.20$2.50$1.42$3.23$4.13
Balance Sheet
2025-12-312024-12-312023-12-312022-12-312021-12-31
Debt / Equity -3.9-2.8-2.4-2.1-2.0
Current Ratio 1.10.91.11.41.3
Quick Ratio 0.40.40.50.60.6
Cash Flow
2025-12-312024-12-312023-12-312022-12-312021-12-31
Free Cash Flow $253M$163M$222M$196M$309M

Latest News Recent headlines mentioning this company

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Institutional owners (13F) 269 filers · $1.2B total · As of June 30, 2026

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
41 (-20 vs prior Q) 42 (+8 vs prior Q) 90 (+9 vs prior Q) 73 (-9 vs prior Q) +4.1M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
Route One Investment Company, L.P. $109,786,720 8,348,800 9.20% Shares
Nantahala Capital Management, LLC $86,790,000 6,600,000 7.28% Call option
VANGUARD PORTFOLIO MANAGEMENT LLC $81,428,443 6,192,277 6.83% Shares
RENAISSANCE TECHNOLOGIES LLC $66,074,384 5,024,668 5.54% Shares
VANGUARD CAPITAL MANAGEMENT LLC $58,016,485 4,411,900 4.86% Shares
GEODE CAPITAL MANAGEMENT, LLC $40,514,448 3,080,442 3.40% Shares
Solel Partners LP $37,452,712 2,848,115 3.14% Shares
STATE STREET CORP $33,478,164 2,545,868 2.81% Shares
TWO SIGMA INVESTMENTS, LP $30,743,240 2,337,889 2.58% Shares
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $29,752,204 2,262,525 2.49% Shares
CITADEL ADVISORS LLC $28,811,650 2,191,000 2.42% Put option
FMR LLC $27,968,275 2,126,865 2.34% Shares
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $27,830,844 2,116,414 2.33% Shares
IRIDIAN ASSET MANAGEMENT LLC/CT $26,671,882 2,028,280 2.24% Shares
Quantedge Capital Pte Ltd $24,273,427 1,845,888 2.04% Shares
DIMENSIONAL FUND ADVISORS LP $23,029,135 1,751,265 1.93% Shares
Long Focus Capital Management, LLC $22,344,480 1,699,200 1.87% Shares
CITIGROUP INC $18,410,000 1,400,000 1.54% Call option
CITIGROUP INC $18,089,903 1,375,658 1.52% Shares
VICTORY CAPITAL MANAGEMENT INC $16,357,588 1,243,923 1.37% Shares
Caption Management, LLC $15,780,000 1,200,000 1.32% Call option
GOLDMAN SACHS GROUP INC $15,559,843 1,183,258 1.30% Shares
Penn Capital Management Company, LLC $15,069,481 1,145,024 1.26% Shares
Nantahala Capital Management, LLC $14,585,375 1,109,154 1.22% Shares
Tenzing Global Management, LLC $13,150,000 1,000,000 1.10% Shares
TWO SIGMA ADVISERS, LP $12,019,925 932,500 1.01% Shares
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC $11,797,786 897,170 0.99% Shares
CITADEL ADVISORS LLC $11,022,330 838,200 0.92% Call option
FIRST TRUST ADVISORS LP $10,198,574 775,557 0.86% Shares
VANGUARD FIDUCIARY TRUST CO $9,024,227 686,253 0.76% Shares
NEW YORK STATE COMMON RETIREMENT FUND $8,941,579 679,968 0.75% Shares
Qube Research & Technologies Ltd $8,218,487 624,980 0.69% Shares
Aristotle Capital Boston, LLC $7,466,962 567,829 0.63% Shares
PANAGORA ASSET MANAGEMENT INC $7,361,817 559,834 0.62% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $7,131,245 542,300 0.60% Call option
MILLENNIUM MANAGEMENT LLC $6,408,639 487,349 0.54% Shares
Manatuck Hill Partners, LLC $6,039,269 459,260 0.51% Shares
Squarepoint Ops LLC $5,633,144 428,376 0.47% Shares
Johnson Financial Group, LLC $5,451,859 414,590 0.46% Shares
Lombard Odier Asset Management (USA) Corp $5,292,875 402,500 0.44% Call option
Trexquant Investment LP $5,265,773 400,439 0.44% Shares
ALGERT GLOBAL LLC $5,263,550 400,270 0.44% Shares
CANTOR FITZGERALD, L. P. $5,167,950 393,000 0.43% Call option
Huber Capital Management LLC $4,841,343 368,163 0.41% Shares
Balyasny Asset Management L.P. $4,707,332 357,972 0.39% Shares
General Equity Holdings LP $4,669,841 355,121 0.39% Shares
CITIGROUP INC $4,602,500 350,000 0.39% Put option
Connor, Clark & Lunn Investment Management Ltd. $4,265,360 324,362 0.36% Shares
BANK OF AMERICA CORP /DE/ $4,261,941 324,102 0.36% Shares
Bronte Capital Management Pty Ltd. $4,252,526 323,386 0.36% Shares
Pekin Hardy Strauss, Inc. $4,129,021 313,994 0.35% Shares
ALLIANCEBERNSTEIN L.P. $4,008,933 272,346 0.34% Shares
GROUP ONE TRADING LLC $3,990,407 303,453 0.33% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $3,951,522 300,496 0.33% Shares
JANE STREET GROUP, LLC $3,814,815 290,100 0.32% Put option
CIBC Private Wealth Group LLC $3,689,284 437,119 0.31% Shares
STATE OF WISCONSIN INVESTMENT BOARD $3,670,152 279,099 0.31% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $3,597,840 273,600 0.30% Put option
XTX Topco Ltd $3,362,179 255,679 0.28% Shares
Quantinno Capital Management LP $3,160,550 240,346 0.26% Shares
Parallax Volatility Advisers, L.P. $3,130,187 238,037 0.26% Shares
JANE STREET GROUP, LLC $3,095,510 235,400 0.26% Call option
Caption Management, LLC $2,956,778 224,850 0.25% Shares
Swiss National Bank $2,729,572 207,572 0.23% Shares
PICTON MAHONEY ASSET MANAGEMENT $2,714,766 206,446 0.23% Shares
MAI Capital Management $2,667,530 202,854 0.22% Shares
Engineers Gate Manager LP $2,662,651 202,483 0.22% Shares
Vanguard Global Advisers, LLC $2,576,874 195,960 0.22% Shares
D. E. Shaw & Co., Inc. $2,336,321 177,667 0.20% Shares
Corient Private Wealth LP $2,330,168 177,199 0.20% Shares
O'SHAUGHNESSY ASSET MANAGEMENT, LLC $2,110,338 160,482 0.18% Shares
Inspire Investing, LLC $2,079,597 141,277 0.17% Shares
JACOBS LEVY EQUITY MANAGEMENT, INC $2,038,105 154,989 0.17% Shares
VANGUARD GROUP INC $1,977,262 153,395 0.17% Shares
Shay Capital LLC $1,972,500 150,000 0.17% Call option
SEGALL BRYANT & HAMILL, LLC $1,820,539 138,444 0.15% Shares
RHUMBLINE ADVISERS $1,808,062 137,496 0.15% Shares
Y-Intercept (Hong Kong) Ltd $1,791,043 136,201 0.15% Shares
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM $1,728,555 117,429 0.14% Shares
Point72 Asset Management, L.P. $1,724,951 131,175 0.14% Shares
DENALI ADVISORS LLC $1,722,650 131,000 0.14% Shares
PRINCIPAL FINANCIAL GROUP INC $1,663,225 126,481 0.14% Shares
Bridgewater Associates, LP $1,524,677 115,945 0.13% Shares
CITADEL ADVISORS LLC $1,519,246 115,532 0.13% Shares
AMERIPRISE FINANCIAL INC $1,481,571 112,667 0.12% Shares
NOMURA ASSET MANAGEMENT INTERNATIONAL INC. $1,473,000 112,000 0.12% Shares
BRIDGEWAY CAPITAL MANAGEMENT, LLC $1,315,000 100,000 0.11% Shares
DIVERSIFY WEALTH MANAGEMENT, LLC $1,272,311 104,459 0.11% Shares
Diversify Advisory Services, LLC $1,272,311 104,459 0.11% Shares
CenterBook Partners LP $1,223,068 93,009 0.10% Shares
WOLVERINE ASSET MANAGEMENT LLC $1,223,055 93,008 0.10% Shares
DGS Capital Management, LLC $1,211,795 82,323 0.10% Shares
DARK FOREST CAPITAL MANAGEMENT LP $1,167,536 88,786 0.10% Shares
BlackRock, Inc. $1,143,919 86,990 0.10% Shares
WOLVERINE TRADING, LLC $1,108,853 130,300 0.09% Call option
TEACHER RETIREMENT SYSTEM OF TEXAS $1,084,441 82,467 0.09% Shares
Arena Capital Advisors, LLC- CA $1,063,967 80,910 0.09% Shares
Graham Capital Management, L.P. $1,057,221 80,397 0.09% Shares
BW Gestao de Investimentos Ltda. $1,052,000 80,000 0.09% Shares
TWO SIGMA INVESTMENTS, LP $1,046,740 79,600 0.09% Put option

Company insiders 95 insiders · 35 officers · 41 directors

Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Stephan Paulo Gratziani Chief Executive Officer May 3, 2026 F 107,310 0 0 $0
John O Agwunobi Chairman and CEO May 10, 2022 P 134,745 0 0 $0
Richard Goudis Chief Executive Officer Sept. 17, 2018 M 861,213 0 0 $0
John Desimone Chief Financial Officer Feb. 25, 2026 A 241,144 0 0 $0
Alexander Amezquita Chief Financial Officer March 3, 2024 F 152,042 0 0 $0
Robert Levy President May 4, 2026 F 11,405 0 0 $0
Gregory Probert President & COO April 4, 2008 A 158,086 0 0 $0
Brian Kane President - Europe Oct. 14, 2005 M 651,442 0 0 $0
Troy Hicks Chief Operating Officer May 18, 2026 M 9,706 0 2 $-619,415
Mark J Schissel Chief Operating Officer April 7, 2023 F 185,090 0 0 $0
David Pezzullo Chief Operating Officer Feb. 26, 2021 F 170,316 0 0 $0
Jehangir D Irani SVP, Chief Accounting Officer May 4, 2026 F 46,371 0 0 $0
Henry C Wang Chief Legal Officer May 4, 2026 F 142,514 0 0 $0
Ibelis Montesino EVP & Chief of Staff May 3, 2024 A 160,812 0 0 $0
Stephen Conchie Regional Pres. APAC & China May 4, 2023 A 81,793 0 0 $0
Edi Hienrich Regional Pres. EMEA & India May 4, 2023 A 34,361 0 0 $0
Alan L Hoffman EVP, Global Corporate Affairs May 17, 2022 P 57,218 0 0 $0
Thomas Harms SVP, China & APAC Feb. 26, 2021 F 30,509 0 0 $0
Jesus Alzarez VP, General Manager, Mexico March 9, 2018 S 2,085 0 0 $0
Jossie Aspauza VP, SAM/CAM March 5, 2018 M 6,546 0 0 $0
Calero Miguel Angel Fernandez EVP, The Americas & WWD Ops May 12, 2017 S 0 0 0 $0
Jerry Li SVP, Managing Director, China May 11, 2017 S 0 0 0 $0
Gioji Okuhara VP, General Manager, Brazil Feb. 23, 2017 A 0 0 $0
Mark J Friedman General Counsel Feb. 23, 2017 A 3,916 0 0 $0
William Rahn SVP / Mg Dir. - Asia Pacific Feb. 11, 2015 A 0 0 0 $0
Brett Chapman Chief Legal Officer Aug. 12, 2014 P 300 0 0 $0
Patricio Cuesta SVP/Managing Director SAM July 22, 2014 M 8,643 0 0 $0
Thomas Zimmer SVP, North America Nov. 30, 2010 A 11,935 0 0 $0
Yair Steve Henig Chief Scientific Officer Oct. 1, 2010 M 9,776 0 0 $0
David Wynne Roberts SVP - EMEA July 29, 2009 A 14,829 0 0 $0
Mora Adriana Gabriela Mendizabal SVP - Mexico & Central America April 2, 2009 A 19,175 0 0 $0
Eneida Bini Senior Vice President, Brazil March 31, 2008 M 1,437 0 0 $0
Percy Chin SVP, Greater China May 29, 2007 A 3,265 0 0 $0
Sergio Medina Gomez SVP, Mexico & Central America May 24, 2007 M 416 0 0 $0
John Purdy Regional Director Asia Pacific May 8, 2006 M 56,200 0 0 $0
Sophie L'Helias Director June 4, 2026 P 79,882 3 0 $29,020
Rodica Macadrai Director May 8, 2026 A 67,441 0 0 $0
Perkins Miller Director May 8, 2026 A 50,769 0 0 $0
Juan Miguel Mendoza Director May 8, 2026 A 181,879 0 0 $0
Lynda Cloud Director May 8, 2026 A 50,736 1 0 $152,490
Maria Otero Director May 8, 2026 A 95,129 0 0 $0
Donal Mulligan Director May 8, 2026 A 68,982 0 0 $0
Richard H Carmona Director May 8, 2026 A 83,645 0 0 $0
Des Walsh Director May 8, 2026 A 61,879 0 0 $0
Michael J Levitt Director May 8, 2026 A 49,393 0 0 $0
Michael Johnson Director Feb. 25, 2026 A 887,415 0 0 $0
Celine Del Genes Director May 2, 2025 A 55,818 0 0 $0
Alan W Lefevre Director May 3, 2024 A 69,117 0 0 $0
Kevin M. Jones Director May 4, 2023 A 19,589 0 0 $0
John Tartol Director Dec. 9, 2022 P 321,793 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

Activists & 5%+ owners 23 positions

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
Icahn Partners Master Fund LP, Icahn Offshore LP, Icahn Partners LP, Icahn Onshore LP, Icahn Capital LP, IPH GP LLC, Icahn Enterprises Holdings L.P., Icahn Enterprises G.P. Inc., Beckton Corp., Carl C. Icahn ×3 filings May 6, 2021 Initial filing SEC
Nov. 5, 2020 Initial filing SEC
Aug. 12, 2020 Initial filing SEC
High River Limited Partnership, Hopper Investments LLC, Barberry Corp., Icahn Partners Master Fund LP, Icahn Offshore LP, Icahn Partners LP, Icahn Onshore LP, Icahn Capital LP, IPH GP LLC, Icahn Enterprises Holdings L.P., Icahn Enterprises G.P. Inc., Beckton Corp., Carl C. Icahn ×14 filings Oct. 30, 2019 Initial filing SEC
May 25, 2018 Initial filing SEC
March 20, 2018 Initial filing SEC
Aug. 21, 2017 Initial filing SEC
March 24, 2014 Initial filing SEC
March 14, 2014 Initial filing SEC
William P. Stiritz ×2 filings Jan. 30, 2014 Initial filing Capital structure SEC
Whitney V, L.P., Whitney Strategic Partners V, L.P., Whitney Equity Partners V, LLC ×4 filings May 4, 2007 Initial filing SEC
April 19, 2007 Initial filing SEC
April 19, 2007 Initial filing SEC
April 9, 2007 Initial filing SEC
April 9, 2007 Initial filing SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF ownership Held by 32 ETFs

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
RSSL · Global X Funds 0.05% 44,299 NS April 30, 2026 N-PORT
DFAS · Dimensional ETF Trust 0.04% 335,706 NS April 30, 2026 N-PORT
DFSU · Dimensional ETF Trust 0.01% 12,198 NS April 30, 2026 N-PORT
DCOR · Dimensional ETF Trust 0.01% 15,531 NS April 30, 2026 N-PORT
MSSM · MORGAN STANLEY PATHWAY FUNDS 0.01% 3,790 NS May 31, 2026 N-PORT
DFAC · Dimensional ETF Trust 0.01% 155,112 NS April 30, 2026 N-PORT
DFAU · Dimensional ETF Trust 0.00% 25,109 NS April 30, 2026 N-PORT
DFUS · Dimensional ETF Trust 0.00% 42,325 NS April 30, 2026 N-PORT
DXUV · Dimensional ETF Trust 0.00% 665 NS April 30, 2026 N-PORT
VXF · VANGUARD INDEX FUNDS July 15, 2026 Daily
VB · VANGUARD INDEX FUNDS July 15, 2026 Daily
VBR · VANGUARD INDEX FUNDS July 15, 2026 Daily
VTI · VANGUARD INDEX FUNDS July 15, 2026 Daily
VFMO · VANGUARD WELLINGTON FUND July 30, 2026 Daily
VFVA · VANGUARD WELLINGTON FUND July 30, 2026 Daily
VTWO · VANGUARD SCOTTSDALE FUNDS July 15, 2026 Daily
VTWV · VANGUARD SCOTTSDALE FUNDS July 15, 2026 Daily
VTWG · VANGUARD SCOTTSDALE FUNDS July 15, 2026 Daily
VTHR · VANGUARD SCOTTSDALE FUNDS July 15, 2026 Daily
ITOT · iShares Trust July 22, 2026 Daily
IWV · iShares Trust Aug. 18, 2026 Daily
IWN · iShares Trust Aug. 17, 2026 Daily
IWO · iShares Trust Aug. 18, 2026 Daily
IWM · iShares Trust Aug. 18, 2026 Daily
PBJ · Invesco Exchange-Traded Fund Trust Aug. 13, 2026 Daily
PRFZ · Invesco Exchange-Traded Fund Trust July 23, 2026 Daily
NEAR · iShares U.S. ETF Trust Aug. 18, 2026 Daily
VDC · VANGUARD WORLD FUND July 20, 2026 Daily
ISCB · iShares Trust July 20, 2026 Daily
ISCV · iShares Trust July 20, 2026 Daily
SMLF · iShares Trust Aug. 10, 2026 Daily
WSML · iShares Trust July 20, 2026 Daily